Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Completed Phase 1 Trials for Interleukin-15, human recombinant (DB17467)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01727076Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerTreatment